Role of epigenetic modulation in cancer stem cell fate
MetadataShow full item record
© 2017 Elsevier Ltd A sub-population of the tumor micro-environment consists of cancer stem cells (CSCs), which are responsible for the initiation and recurrence of cancer. Recently, epigenetic processes such as DNA methylation, histone modification, and chromatin remodeling have been found to be involved in inducing epigenetic factors in CSCs. Most of these processes, such as DNA methylation, generally occur in the genome that is rich in Cytosine-Guanine repeat sequences, also known as CpG islands, which are distributed throughout the human genome. The Polycomb gene (PcG) complex is a chromatin modifier facilitating the maintenance of embryonic and adult stem cells. Recent evidence suggests that the PcG is also involved in maintaining CSC stemness. We have presented various aspects and examples of how epigenetic modulation may drive or promote tumorigenesis and metastasis by alteration of key transcriptomic programs and signaling pathways in CSCs.
Showing items related by title, author, creator and subject.
Epigenetic reprogramming converts human Wharton's jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediatorsBhuvanalakshmi, G.; Arfuso, Frank; Kumar, Alam Prem; Dharmarajan, Arunasalam; Warrier, Sudha (2017)BACKGROUND: Lineage commitment of mesenchymal stem cells (MSCs) to cardiac differentiation is controlled by transcription factors that are regulated by epigenetic events, mainly histone deacetylation and promoter DNA ...
Shanmugam, M.; Arfuso, Frank; Arumugam, S.; Chinnathambi, A.; Jinsong, B.; Warrier, Sudha; Wang, L.; Kumar, A.; Ahn, K.; Sethi, G.; Lakshmanan, M. (2018)© Shanmugam et al. Oncogenesis is a multistep process mediated by a variety of factors including epigenetic modifications. Global epigenetic post-translational modifications have been detected in almost all cancers types. ...
Bridgeman, S.; Ellison, G.; Melton, Phillip; Newsholme, Philip; Mamotte, Cyril (2018)© 2018 John Wiley & Sons Ltd. There is a growing body of evidence that links epigenetic modifications to type 2 diabetes. Researchers have more recently investigated effects of commonly used medications, including those ...